Casp1−/−Casp11−/−
|
Leishmania amazonensis |
Increased lesion size and parasite burden in ear, lymphnode and spleen (159). |
Leishmania major |
Decreased footpad swelling, decreased pathology score and parasite burden in the footpads, decreased IL-1β and IL-18 in the footpads, decreased IL-4, IL-5 and increased IFN-γ (160), decreased infiltration of CD11b+ and PMN cells in the ear (216). |
Plasmodium berghei |
No difference in survival when infected with sporozoites or iRBCs and no difference in parasitemia level (217, 218). |
Toxoplasma gondii |
Reduced survival and decreased IL-1β and IL-18 in the serum (161). |
Trypanosoma cruzi |
Reduced survival, higher parasitism in the heart, spleen and blood, higher heart injury, decreased IL-1β (162, 163), decreased production of NO from splenocytes (163). |
Casp11−/−
|
Toxoplasma gondii |
Increased survival, decreased clinical score, altered immune responses, increased brain cysts and neuroinflammation during late stages of disease (164). |